Author Question: A client is prescribed ticlopidine (Ticlid) after a myocardial infarction and stent placement. How ... (Read 59 times)

s.tung · **on:** Jul 23, 2018

A client is prescribed ticlopidine (Ticlid) after a myocardial infarction and stent placement. How should the nurse explain the action of this medication to the client?

Standard Text: Select all that apply.
1. Ticlid will dissolve any clots that might form in your stent.
2. Ticlid will make the platelets in your blood less sticky.
3. Ticlid will change the way your platelets work their entire lives.
4. Ticlid decreases your blood's ability to clot.
5. Ticlid works just like the heparin you have been on in the hospital.

Question 2

A client is being treated for a thromboembolic disorder. If the goal is to prevent clot formation, the nurse anticipates the client will be treated with which classifications of drug?

Standard Text: Select all that apply.
1. Hemostatics
2. Thrombolytics
3. Anticoagulants
4. Antiplatelet agents
5. Clotting factor concentrates

skipfourms123 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 2,3,4
Rationale 1: Ticlid does not act to dissolve clots.
Rationale 2: Ticlid is an adenosine diphosphate (ADP) receptor blocker that acts to make platelets unable to aggregate, thus rendering them less sticky.
Rationale 3: Ticlid causes irreversible changes in platelet plasma membranes.
Rationale 4: Ticlid does decrease the blood's ability to clot.
Rationale 5: The mechanisms of action of Ticlid and heparin are not alike.
Global Rationale: Ticlid is an adenosine diphosphate (ADP) receptor blocker that acts to make platelets unable to aggregate, thus rendering them less sticky. Ticlid also causes irreversible changes in platelet plasma membranes and decreases the blood's ability to clot. Ticlid does not act to dissolve clots. The mechanisms of action of Ticlid and heparin are not alike.

Answer to Question 2

Correct Answer: 3,4
Rationale 1: Hemostatic drugs are given to inhibit fibrin destruction, thereby promoting clot formation.
Rationale 2: Thrombolytic drugs are given to remove existing clots by dissolving them.
Rationale 3: Anticoagulants inhibit specific clotting factors, thereby preventing clot formation.
Rationale 4: Antiplatelet agents inhibit the action of platelets, thereby preventing clot formation.
Rationale 5: Clotting factor concentrates replace missing clotting factors, thereby promoting clot formation.
Global Rationale: Anticoagulants inhibit specific clotting factors, thereby preventing clot formation. Antiplatelet agents inhibit the action of platelets, thereby preventing clot formation. Hemostatic drugs are given to inhibit fibrin destruction, thereby promoting clot formation. Thrombolytic drugs are given to remove existing clots by dissolving them. Clotting factor concentrates replace missing clotting factors, thereby promoting clot formation.